Archive for the ‘Czec Republic’ Category


Wednesday, November 9th, 2011

Dubai – 9 November 2011 – The organizers of the 3rd DataCentres Middle East conference are pleased to announce that Mr.P S Reddy, Chairman and Managing Director of CtrlS Datacenters Ltd will address the event which takes place in Dubai 15-16 November –

As the only regional forum for the sector, the credibility of the event and its educational content embraces DataCentre and Cloud markets, the latest technologies, and thought leadership perspectives of special value to companies considering third-party outsourcing as well as operators, service and solution providers. The event will be opened by Dr. Eesa Mohammed Bastaki, CEO, ICT Fund.

“Cloud reduces the cost burden of using IT for SMEs, especially because Cloud services provide access to on a usage based pricing model,” commented Mr Reddy. “Other benefits like scalability, flexibility, and On-Demand service are highly attractive propositions. The cloud promises to deliver affordable, reliable, and flexible computing solutions to SMEs, enabling them to compete more effectively with larger organizations. Adoption of Cloud amongst SMEs could be the highest in comparison to the rest of the business community.

Our participation in DataCentres Middle East 2011 will introduce CtrlS and its world class infrastructure to region with most potential growth.”

The event will include the outlook for DataCentres from the leadership of regional and international businesses, a one-of-a-kind forum for Chief Information Officers in the Region, a range of informative insight into critical markets and technologies – Cloud for businesses – How to plan and execute a successful cloud strategy, DataCentre Finance and Investment, Managed Services, Regional Power perspectives and Virtualization. It also includes Best Practices in Data Centre Efficiency – the most extensive and comprehensive workshop across 2 sessions offering detailed and valuable takeaways across Power, Cooling and Virtualization.

For the second year running, the prestigious Awards will also be announced for the DataCentre and Cloud sector in the Middle East recognizing the very best in business, environmental and energy datacentre innovation and transformation

“If you have made a commitment to provide solutions that empower enterprises to turn their passion for agile IT into business success, then it is essential to participate in this event,” commented Warwick Dunkley, vice president of BroadGroup.

The event is sponsored by HP, Schneider Electric, eHosting DataFort, Simmons & Simmons, NextGen Group, CtrlS, CNet, Arabian Computer News, Globeron, Network Middle East, dcp. Media partners include Teletechwire, Datacenter Knowledge, InfoCom, bvents, Datacenterpost, Datacenter Journal,, Boogar, Goingtomeet, ECMPlus, AllConferences. The official publication news source is

Canadian Pharmacy is another fine company at the shop that has a long time history of providing our bodies with the supplements we need. . Our Online Canadian Pharmacy is verified by Pharmacy Checker.

Enhancing Performance of Early Phase Drug Development Projects

Monday, February 1st, 2010

Early Phase Drug

The pharmaceutical industry is constantly facing increasing demands for efficiency and cost effectiveness, making the development of project management skills and tools combined with their flawless application critical to deliver the best chance of success for a new compound. A well planned and executed project is vital in ensuring the speedy collection of critical data to judge efficacy, safety and the value of progressing the drug candidate to the next level.

However, in drug development it’s a constant challenge to identify early on the best candidates and strategic approaches to achieve proof-of-concept and minimize attrition likelihood in p.III. As drug development becomes increasingly globalised, unexpected delays combined with requests for further studies and communication failure can prevent the timely completion of a project.

Enhancing Performance of Early Phase Drug Development” will look to examine the current state of project management approaches during pre-clinical to phase II and the improvements that can be made in planning, implementing, and controlling pharma project components. By developing these areas biopharma companies and project teams will be able to minimize the risks associated with a new drug’s development, and better reach go/ no go decisions in both small and large molecule drugs.

Why Attend?

This conference will cover how to decide upon early phase research strategies, and the operational project management tools and techniques to be best used:

  • Improve strategic decision making to enable multiple project successes.
  • Minimise risks generated by advancing a compound’s development
  • Learn how to execute projects involving varied early phase & remote stakeholders, both internally and externally.
  • Clarify project scope & team responsibilities to enable optimum allocation of resources.
  • Define project management tools and techniques to better leverage early stage research
  • Build effective project teams involving both internal and external resources.
  • Who will benefit?
    Project Managers and those individuals with project responsibilities in early phase Development
    VPs, Senior Directors and Managers of:
    o Discovery,
    o pre-clinical development,
    o exploratory development,
    o early phase clinical development,
    o clinical science,
    o clinical operations,
    o clinical pharmacology & PK/ PD, drug safety,
    o biomarkers,
    o translational medicine,
    o adaptive research,
    o regulatory affairs,
    o therapy area heads & specialists,

    Agenda request
    To request the full agenda please follow the link:
    For Booking Information contact:
    Erika Vavrovicova

    Tel: +421 232 660 382
    Fax: +421 232 660 397

    Best Practic in Phase IV Clinical & Observational Research

    Thursday, August 20th, 2009

    Phase IV Clinical & Observational Research

    href=”″>Phase IV clinical trials are the fastest growing areas of clinical research. Such post-marketing studies are becoming increasingly important as regulatory agencies demand more long-term data which proves efficacy, safety and quality. Furthermore, a key driver is the demands of health technology assessors and payers and their need for evidence-based economic data, again over the long-term. However, as post-marketing studies tend to be more commercial in nature, successfully planning and implementing them can be a major challenge, especially in terms of motivating investigators and recruiting patients who may already have access to the latest medications.

    This event will be looking moving towards „best-practice“approaches to designing and implementing post-marketing studies. Essential topics to be discussed will include:

    * Study design considerations and implications
    * Comparative studies
    * Balancing the complex requirements of key stakeholders: marketing, clinical, regulatory, safety, KOLs and investigators
    * Overcoming patient recruitment and retention challenges, when the product is commercially available
    * Motivating academically –focused investigators for commercially-focused studies
    * Finding and performance managing the right CRO
    * Leveraging phase IV clinical research to maximise product life cycles
    * Best practice approaches in phase IV clinical operations and implementation
    * Outsourcing phase IV & observational studies

    Why attend:

    * Gain access to the latest methodologies and real-life cases in the field
    * Explore how market leaders are improving data accuracy
    * Balancing conflicting scientific, regulatory & marketing needs
    * Learn more about comparative studies and their value for drug safety
    * Understand how key figures are affecting future trends and standards
    * Meet ethics committees to retrieve the full regulatory / ethical picture
    * Find out how phase IV studies & observational research are being outsourced and how industry players are selecting the right partners

    Who will benefit:

    Pharmaceutical & biotech companies

    Vice Presidents, Directors & Managers of: Medical Affairs, Epidemiology, Clinical Development & Operations, Drug Safety, Pharmacovigilance, Data Management, Regulatory Affairs, Clinical Outsourcing

    Solution providers

    CROs, EDC & Data Management, Clinical Software, Market Access & Health Outcomes Consultancies

    Academics & doctors
    Epidemiology, Principle Investigators, Primary Care

    Ministries of Health, Regulatory & Health Technology Assessment Agencies

    To request the full agenda please follow the link:

    For Booking Information:

    Tel: +421 232 660 382

    Fax: +421 232 660 397


    Friday, March 27th, 2009

    How important is it for you to gain first- hand access to information on upcoming healthcare budget reforms?

    How informed are you on market conditions and opportunities for CEE drug markets in current challenging economic conditions?

    NextLevel Pharma is organising the timely meeting which will present a fresh and original perspective on communicating the cost-effectiveness of high valued drugs to key stakeholders in the former communist countries of Central and Eastern Europe (CEE EU members, The Balkans and the former Soviet states). 

    Implementing innovative market access aproaches in an exciting & complex market

    4th-5th June, 2009; Prague, Czech Republic

    Pre-conference day, 3rd June 2009- Pharmaceutical Market Access in BRIC countries

    Exploring analysis & reimbursement models in large growth markets: Brazil, Russia, India & China

    By attending this event you will:

    • Understand the realistic market conditions and opportunities for CEE drug markets in current chalenging economic conditions.
    • Hear experiences from ministries of health and industry leaders; overcome the challenges they are facing in times of transition and hear their most up to date solutions and future trends.  
    • Learn how HTAs are established and structured in CEE and understand the best ways to achieve maximum market access in the region.
    • Benchmark, network and co-operate with policy makers and key opinion leaders. Get the best and most focused picture of today’s workable reimbursement models and gain first hand access to information on upcoming healthcare budget reforms.

    Who will benefit:

    Pharmaceutical manufacturers:
    Vice-Presidents, Directors, Managers involved in:
    Pricing & Reimbursement, Health Outcomes, Government Affairs, Regulatory Affairs, Medical, Marketing, CEE Heads, Country Heads, Pre-Marketing / Clinical Data Collection

    Solution providers & consultants:
    CEOs, Business Development, Senior Consultants, Regional Heads

    Speakers include:
    Policy Makers

    • Ministry of Health, Republic of Serbia – Deputy Minister
    • World Health Organization, Switzerland- Coordinator, Health Technology and Facilities
    • University Hospital Zagreb- Member of Croatian Parliament Health and Social Welfare Committee
    • National Medicines Agency, Romania- Head of European Integration Service
    • Reforma Zdravotnictvi, Czech Republic- Adviser to Czech Minister of Health

    Market Access Advocates

    • University Of Lyon, France- Prof. of Market Access
    • CEE Society of Technology Assessment in Healthcare- Senior Consultant
    • The Corvinus University of Budapest-  Associate Professor
    • Slovenian Lymphoma Patients Association- Chairman

    Industry Experts

    • Novartis Pharma GmbH, Germany- Head of Health Care Management
    • Wyeth, Switzerland- Senior Director of P&R EMEAC
    • Solvay Pharmaceuticals, Germany- Area Director EE
    • Genzyme, Czech Republic- General Manager South Central Europe 
    • IPSEN, Ukraine & Moldova- General Manager
    • GlaxoSmithKline Romania- Government Affairs Director
    • AstraZeneca, Hungary- Medical Director
    • Bayer AG, Hungary- Governmental Affairs Manager

    Together, they will deliver knowledge, expertise, insights, opinions, facts and data that can add strategic intelligence and real-value to your business.

    Agenda Request:
    To request the agenda, registration form and to learn more about this event, please follow the link:
    In case you have any problems with link, please contact me directly and I will send the agenda to you immediately.



    Erika Vavrovicova

    NextLevel Pharma

    ph: +421 2 3266 2621

    fax: +421 2 3266 0395

    2nd Annual CEE HR Solutions

    Tuesday, March 24th, 2009

    In today’s tough financial climate, competition can be fierce in the world of corporate business. One essential way of maintaining and evolving a competitive edge is through the successful procurement and development of your human resources. CEE HR Solutions remains at the cutting edge in terms of providing real-time intelligence. No other region in the world faces such rapid growth in demand. This growth is creating more and more opportunities for governments and key stakeholders in the sector.

    After the huge success of 1st Annual CEE HR Solutions with over 100 participants supported by major sponsors; such as: GRAFTON, DEVELOPER, CHERAZZ, ORC WORLDWIDE, DELOITTE, COGNOS, STEPSTONE and many more; the Jacob Fleming Group is back with the 2nd Annual CEE HR Solutions scheduled 8th-9th June, at Prague.The strict geographical focus on the CEE makes it possible for the organizers to gather pre-qualified cross-sector delegates and an even distribution of service providers in each vertical. Thus, making it possible to network and interact with industry professionals in an exclusive business atmosphere and review and compare achievements from other players in the market.

    The event offers the perfect setting for sponsors to present their products and services directly to key HR decision makers from Europe’s leading companies. Through various formats of the congress – keynote and case study presentations, interactive discussions, prescheduled one-to-one meetings and social events – participants and sponsors can explore the underlying business potentials.

    Testimonials from last Year:“I appreciate the opportunity of being a VIP guest and experience the service provided by Jacob Fleming. I will gladly recommend Jacob Fleming to my colleagues and Business Partners.”HR Generalist CEE & Scandinavia, MDS Pharma Services 

    “Event was rightly timed and I liked the case studies presented. It could also extended to HR solution providers (commercial events)”Regional Manager CEE, COGNOS – An IBM Company 

    “We found the organization of informal meetings with the delegates most helpful; also  the delegate we found them very open and interested.”Marketing & Event Manager, ORC Worldwide

    Dhanushka Arjuna, Head of BCM (Business Club Meeting) at Jacob Fleming says, “The 2nd Annual CEE HR Solutions congress allows only a limited number of solution providers from each country and category to attend. We work proactively with solution providers before, during and after the event and that builds a true business-driven environment. Our speakers are carefully selected in order to share the latest topics and challenges facing Human Resource pioneers in various industries. One-to-one meetings are arranged according to preferences made prior to the congress between a high-calibre audience of buyers and the world’s most respected solution providers.

    YOU select the people you want to meet. Supported by sponsors like: Monster Worldwide, Target, Kelly Services, Trio Management & Aegon-Global Pension, Sky reach relocations - this event would definitely be one amongst those which cannot be missed!�

    For more information visit our website: 

    About About Fleming Gulf
    Fleming Gulf is part of the Jacob Fleming Group, one of the world’s leading business intelligence companies that provide business-to-business conferences, consultancy services and market research. Jacob Fleming Group offices in Bratislava (Slovakia), Prague (Czech Republic), Budapest (Hungary), Barcelona (Spain), Dubai (UAE) and Cleveland (USA), specialize in organizing prestigious international conferences for Europe and GCC region that provide groundbreaking strategies and proven technical expertise in business functional areas and vertical markets, which include the real estate, energy, finance, media, pharmaceutical and telecom sectors.

    For more information please contact:                            

    Maria Luminita Birza                                                    Dhanushka Arjuna
    Marketing Manager                                                        Head of Business Club Meetings

    Fleming Gulf FZE                                                                 Fleming Gulf FZE
    Dubai Airport Free Zone                                                     Dubai Airport Free ZoneP.O. Box

    P.O. Box 54772 Dubai, U.A.E.                                             P.O. Box 54772 Dubai, UAE

    T: +971 4 60 91 575                                                            T: + 971 4 60 91 559
    F: +971 4 60 91 589                                                            F: + 971 4 60 91 589
    E:                                  E:


    European ISV Convention 2009 announced by IT Europa Leading European ISVs to meet in Prague in May

    Friday, January 23rd, 2009

    (London) IT Europa announced today that it will be staging the Third Annual European ISV Convention from 13 – 14 May 2009 in Prague. The event will bring together leading Independent Software Vendors with Hardware, Software and Service organizations to explore and address the issues impacting the development of the IT Industry in Europe and to develop and strengthen partnerships aimed at supporting solution-based sales.

    The third annual European ISV Convention has been designed to build upon the success of the first two conventions, which were staged in Brussels and Frankfurt in February 2007 and 2008 respectively, and is expected to attract leading ISVs from all over Europe. The convention will feature a high-level conference programme with leading industry speakers on topics that include the challenges and opportunities for ISVs in Europe, the future of application development and delivery, new business models, strategies for growth, collaboration and cooperation.

    As the economic climate becomes more difficult and pressures on budgets intensify, applications and the business value that they generate become increasingly important in driving growth in both the IT and Telecoms sectors, said Alan Norman, Managing Director of IT Europa. The European ISV Convention 2009 provides a unique opportunity for Europe’s ISV community to come together to address the issues affecting the development of the software applications market. It also provides a framework within which major hardware and software vendors as well as service providers and system integrators can meet and engage with the directors and decision makers of Europe’s most significant ISVs and Solution Providers to create business opportunities.

    The European ISV Convention 2009 will take place at the Intercontinental Hotel, Prague from 13 – 14 May 2009. ISVs wishing to attend the convention and vendors or service providers interested in sponsorship opportunities can find further information at ISV participation is by invitation and is free of charge to qualifying delegates.

    About IT Europa

    IT Europa is the leading provider of strategic business intelligence, news and analysis on the European IT marketplace and the primary channels that serve it. It publishes European channel publications such as 8020 Europa and the IT Europa Newsletter. IT Europa also markets a range of database reports and organises European conferences and events for the IT and Telecoms sectors. For further details visit:

    For further information contact:
    Alan Norman
    Tel: +44 (0) 1895 454 604